178 related articles for article (PubMed ID: 27170186)
21. Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines.
Seo HW; Lee J; Han K; Park C; Chae C
Res Vet Sci; 2014 Aug; 97(1):38-42. PubMed ID: 24794246
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets.
Gamage LN; McIntosh KA; Parker S; Harding J; Krakowka S; Ellis J
Can J Vet Res; 2012 Oct; 76(4):301-7. PubMed ID: 23543956
[TBL] [Abstract][Full Text] [Related]
23. Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.
Seo HW; Oh Y; Han K; Park C; Chae C
BMC Vet Res; 2012 Oct; 8():194. PubMed ID: 23078878
[TBL] [Abstract][Full Text] [Related]
24. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
[TBL] [Abstract][Full Text] [Related]
25. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
Seo HW; Han K; Park C; Chae C
Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
[TBL] [Abstract][Full Text] [Related]
26. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination.
Opriessnig T; Patterson AR; Madson DM; Pal N; Ramamoorthy S; Meng XJ; Halbur PG
Vet Microbiol; 2010 May; 142(3-4):177-83. PubMed ID: 19913369
[TBL] [Abstract][Full Text] [Related]
28. Multiple routes of porcine circovirus type 2 transmission to piglets in the presence of maternal immunity.
Dvorak CM; Lilla MP; Baker SR; Murtaugh MP
Vet Microbiol; 2013 Oct; 166(3-4):365-74. PubMed ID: 23867083
[TBL] [Abstract][Full Text] [Related]
29. Exploratory field study on the effect of Porcine circovirus 2 (PCV2) sow vaccination on serological, virological and reproductive parameters in a PCV2 subclinically infected sow herd.
Oliver-Ferrando S; Segalés J; López-Soria S; Callén A; Merdy O; Joisel F; Sibila M
BMC Vet Res; 2018 Apr; 14(1):130. PubMed ID: 29661203
[TBL] [Abstract][Full Text] [Related]
30. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
[TBL] [Abstract][Full Text] [Related]
31. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
[TBL] [Abstract][Full Text] [Related]
32. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
[TBL] [Abstract][Full Text] [Related]
33. Immune responses of piglets immunized by a recombinant plasmid containing porcine circovirus type 2 and porcine interleukin-18 genes.
Chen GL; Fu PF; Wang LQ; Li XS; Chen HY
Viral Immunol; 2014 Dec; 27(10):521-8. PubMed ID: 25268976
[TBL] [Abstract][Full Text] [Related]
34. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
35. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.
Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M
J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118
[TBL] [Abstract][Full Text] [Related]
36. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
[TBL] [Abstract][Full Text] [Related]
37. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.
Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
Clin Vaccine Immunol; 2010 Dec; 17(12):1940-5. PubMed ID: 20926694
[TBL] [Abstract][Full Text] [Related]
38. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity.
Fraile L; Grau-Roma L; Sarasola P; Sinovas N; Nofrarías M; López-Jimenez R; López-Soria S; Sibila M; Segalés J
Vaccine; 2012 Mar; 30(11):1986-92. PubMed ID: 22245604
[TBL] [Abstract][Full Text] [Related]
39. Memory T cell proliferative responses and IFN-γ productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease.
Ferrari L; Borghetti P; De Angelis E; Martelli P
Vet Res; 2014 Apr; 45(1):44. PubMed ID: 24735253
[TBL] [Abstract][Full Text] [Related]
40. Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
Venegas-Vargas C; Taylor LP; Foss DL; Godbee TK; Philip R; Bandrick M
Vaccine; 2021 Sep; 39(39):5615-5625. PubMed ID: 34420789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
